Book summary “Can't Remember What I Forgot”: summary

Introduction

You likely panic every time you walk into a room and forget why you went there, instantly fearing Alzheimer's disease. Society suffers from a mass phobia regarding memory loss, routinely confusing normal everyday memory lapses with pathological neurodegeneration.

Sue Halpern investigates this widespread anxiety in Can't Remember What I Forgot: The Good News About the Brain. You learn that normal age-related memory decline is distinct from true disease, and you can protect your brain through deliberate lifestyle choices and cognitive reserve.

The book takes you inside advanced neuroimaging laboratories, pharmaceutical companies, and neuroscience facilities to reveal how your brain actually ages.

You will find answers to several crucial questions:

• How do you distinguish normal forgetfulness from early Alzheimer's disease?
• What happens inside your neural architecture as you grow older?
• Can diet and exercise genuinely stimulate new brain cells and prevent cognitive decline?

1. Anxiety and Public Perception

The Fear of Forgetting

Society suffers from a mass phobia regarding memory loss and Alzheimer's disease. You worry about ordinary memory lapses that leak throughout the day.

A Modern Maturity survey reported specific fears:

• 83 percent of people worried about forgetting names;
• 60 percent concerned about misplacing car keys;
• 57 percent disturbed about recalling phone numbers.

Younger individuals attribute these slips to stress. Older adults frequently fear it signifies the onset of Alzheimer's disease. Media coverage and health-oriented newsletters amplify this dread. In a 2002 survey, 95 percent of respondents considered Alzheimer's disease a serious problem, and 64 percent of baby boomers worried about getting it.

Statistics and Odds

Alzheimer's prevalence and incidence differ significantly, leaving most individuals disease-free despite alarming public numbers.

Prevalence measures existing cases, which are projected to surge as the population ages. Projections estimate that by 2050, the number of people with Alzheimer's will reach 16 million in the United States, 16.5 million in Europe and the UK, and 62.8 million in Asia. Worldwide, 106 million people are expected to suffer from the condition by 2050. Currently, 5 percent of the American population already has Alzheimer's, and someone develops the disease every 72 seconds.

Incidence measures new cases, showing a more reassuring reality. Starting at age sixty-five, you have roughly a 10 percent chance of developing Alzheimer's. That leaves a 90 percent chance of remaining disease-free.

Memory decline happens to everyone as you grow older. Researchers at the University of Maastricht surveyed 4,000 people and found distinct results across ages:

• one in two people over sixty-five reported forgetfulness;
• one in three people between twenty-five and thirty-five reported memory problems.

Scientists study normal aging as a new frontier. Disease involves specific abnormal brain alterations, but mild age-related memory changes occur universally.

2. Brain Imaging and Diagnostics

Advanced neuroimaging and early screening tests allow clinicians to measure brain structures and identify mild cognitive impairment before clinical symptoms emerge.

Pathology and Scans

Alzheimer's disease pathology has traditionally been defined by beta-amyloid plaques and neurofibrillary tangles. Plaques consist of beta-amyloid protein clusters resembling wads of chewing gum distributed throughout the brain. Neurofibrillary tangles look like strands of hair found inside brain cells.

Dr. Alois Alzheimer described the pathology in 1906 in a younger patient. He observed these changes long before senile dementia in older patients was recognized as the same disease.

Structural MRIs reveal brain architecture and volume. Functional MRIs track blood flow and oxygen use in active regions. In an Alzheimer's brain, overall shrinkage and atrophy cause the fluid-filled cavities called ventricles to expand and the surrounding cerebral spinal fluid layer to widen.

Mony de Leon at NYU first measured brain atrophy in 1979. He used structural MRIs in a study funded by the National Institutes of Health to find predictors for Alzheimer's and mild cognitive impairment.

Subtle structural changes and lesions in the brain's white matter are common in aging and correlate with memory performance. Dr. Jelle Jolles and Ian Deary found that microscopic damage or lesions in the white matter appear frequently even in people without dementia.

Ian Deary and collaborators tracked participants from the June 1, 1932 Scottish Mental Survey of 87,498 children. They recruited eighty-two survivors at age seventy-eight for cognitive testing and brain MRI scans. Participants exhibiting these bright white matter abnormalities on scans performed worse on cognitive tests.

Early Diagnostic Tools

Olfactory tests that measure the ability to identify specific odors can serve as early warning signals for mild cognitive impairment and Alzheimer's disease. Simple odor identification tests help predict cognitive decline before memory loss fully manifests.

Researchers at the University of Maastricht and Columbia University tested subjects with scratch-and-sniff items like strawberry, smoke, soap, and leather. Misidentifying multiple smells correlated with a higher risk of developing Alzheimer's.

• Present smells such as strawberry, smoke, soap, menthol, clove, pineapple, natural gas, lilac, lemon, and leather to test subjects.
• Identify misidentifications of two or more smells as an early indicator of increased Alzheimer's risk.

Subjects misidentifying two or more smells were five times as likely to develop Alzheimer's over six years of subsequent memory loss tracked in the Maastricht Aging Study.

Virtual reality environments can reveal preserved visual memory reserves and diagnose early memory deficits that traditional paper-and-pencil tests miss. Professor Skip Rizzo used a virtual office and a virtual theater at the University of Southern California to assess patients. Individuals who performed poorly on word-list tests still retained functional visual memory in interactive spaces.

• Put on a tracking headset and visor to enter a virtual environment.
• Scan the virtual room containing various objects and listen to an experimenter name them.
• Recall and replace missing objects in their exact previous locations.
• Navigate through a virtual amphitheater to find a specific numbered seat.

These virtual tasks involved sixteen objects placed in the virtual office environment and seat number 257 in the amphitheater.

Standard word-recall tests are effective early screening tools for distinguishing between normal aging and mild cognitive impairment leading to Alzheimer's. Healthy individuals encode and retain words through repetition and delay. Individuals with Alzheimer's fail to benefit from repetition because their core deficit lies in the inability to recall information.

• Administer a ten-word recall test to the patient.
• Introduce a delay to check for memory decay.
• Observe whether the patient benefits from repetition or fails to recall information.
• Conduct annual screenings after the age of fifty.

Dr. Rod Shankle published a paper showing that standard ten-word recall tests accurately discriminate between normal individuals and those with mild cognitive impairment who are likely to develop Alzheimer's.

3. Neuroscience and Memory Mechanics

Memory relies on complex neural architecture, synaptic plasticity, and distinct cognitive categories that are vulnerable to stress and biological flaws.

Neuroscientists and psychologists parse memory into distinct categories linked to specific brain regions and temporal durations.

• declarative memory for facts, events, and ideas;
• implicit memory for skills and muscle movement;
• episodic memory for personal experiences;
• semantic memory for general concepts;
• working memory for holding and manipulating information temporarily;
• sensory, short-term, and long-term memory.

Procedural memory is linked to the cerebellum. Working memory heavily involves the prefrontal cortex, and short-term memory relies on the cashew-shaped hippocampus.

Anatomy of the Brain

The human brain contains 100 billion neurons, matching the 100 billion stars in the Milky Way. Structurally, it consists of lobes such as the temporal, frontal, parietal, and occipital lobes. Signals travel between neurons when an axon sends a message to a dendrite across a synapse using ephemeral chemicals called neurotransmitters.

Randy Buckner explained at Harvard using a 7-tesla MRI how the brain computes sound localization by combining loudness and timing differences calculated in separate brain regions. The hippocampus is crucial for forming short-term memories and spatial navigation, and its early deterioration is a hallmark of Alzheimer's disease. Damage to or removal of the hippocampus prevents the formation of new memories while leaving remote past memories intact.

A nine-year-old boy fell off his bicycle in 1946 and developed severe seizures, leading a doctor to remove parts of his temporal lobe and hippocampus. The surgery cured his seizures but left him unable to form any new memories for the rest of his life. Brenda Milner published the first papers about H.M. in 1957. The hippocampus remains relatively stable in volume until age sixty, after which it shrinks due to a loss of synapses.

Chronic or acute stress floods the brain with hormones like cortisol and catecholamines, impairing prefrontal cortex circuits and degrading memory retrieval. Yale professor Amy Arnsten explained that unstudied students go blank during exams due to the disconnection of prefrontal cortex circuits caused by catecholamines.

• Relax and breathe to allow the disconnection of prefrontal cortex circuits to pass.

Cellular Mechanisms of Learning

Learning and long-term memory storage depend on functional and structural plasticity at the synaptic connections between neurons. Eric Kandel used the giant marine snail Aplysia to demonstrate that learning alters the strength and number of synaptic connections rather than individual neuron properties. Kandel took 15 years to be in a position to answer questions about long-term memory.

Kandel studied Aplysia and its 20,000 neurons clustered in ganglia to understand the gill-withdrawal reflex. In 1971, Kandel and his group published a paper laying out their cyclic AMP theory. Repeated stimulation triggers neurotransmitters like serotonin and glutamate, activating cyclic AMP and protein kinase A to solidify long-term memory.

• Train slowly and spread out learning over several days rather than intensely all at once to establish long-term memory.

Spatial memory can be tested using the Morris water maze, which demonstrates the functional role of the hippocampus in spatial navigation. Mice were tested on the 12th floor at Columbia in a white plastic tub filled with opaque water and a submerged platform, using objects like a blow-up dinosaur and an inflatable cheetah suspended from the ceiling as visual referents.

• Place the mouse on the platform for twenty seconds so it knows it is there.
• Remove the mouse and release it somewhere else in the pool, giving it a minute to find its way back.
• Allow the mouse to stay on the platform for twenty seconds if it finds it, or place it there manually for twenty seconds if it fails.

Positron-emission tomography tracks radioactive isotopes to measure glucose metabolism in the brain, revealing that cognitive decline involves failures in attention alongside memory. Research by Dr. Susan De Santi at NYU showed that mild cognitive impairment patients are much more likely to convert to Alzheimer's disease when memory problems are combined with deficits in other domains like attention or fluency. Specifically, 71 percent of people with memory problems and another cognitive problem developed Alzheimer's disease, compared to only 8 percent of people with memory problems alone.

The author underwent a PET scan at Brookhaven National Lab, involving an intravenous radioisotope and an arterial line drawing blood every few seconds while immobilized in a foam helmet.

• Drink a large amount of liquids after a PET scan to accelerate the elimination of radioactivity.
• Wash hands thoroughly after using the bathroom following the scan.

4. Defining Normal Aging and Compensation

Being clinically normal provides no guarantee against future disease. Researchers debate whether Alzheimer's disease is an accelerated pathology or an inevitable consequence of living beyond evolutionary design.

The aging brain compensates for physiological shrinkage through bilateralism and molecular pathways that preserve cognitive function.

Harvard neuroscientist Randy Buckner suggests that many advanced aging changes might be a preprogrammed developmental course expressed past evolutionary limits. This course remains distinct from detrimental disease events like Alzheimer's that target specific regions.

Randy Buckner observed changes in his own thirty-five-year-old brain. He discussed how longitudinal studies reveal that a normal test result today does not guarantee a normal result in the future. Scientists speculate about twenty years or fifty years as incubation periods for when a disease like Alzheimer's might begin.

Neural Compensation

To maintain cognitive performance despite the physiological shrinkage of aging, the brain recruits additional resources by engaging both hemispheres instead of just one.

Duke University researchers led by Roberto Cabeza discovered that high-functioning older adults recruit the underused left half of the prefrontal cortex to maintain performance. This process of neural compensation is similar to using both hands to lift a heavy bag.

Normal aging and Alzheimer's disease target distinct, separate nodes within the hippocampal circuit. Scott Small invented a new high-resolution MRI technique to peer into hippocampal subregions. He discovered that normal aging primarily targets the dentate gyrus, whereas Alzheimer's disease predominantly makes the entorhinal cortex vulnerable.

Scott Small demonstrated his findings in December 2004 by drawing loops on a blackboard, explaining how breaking different nodes in the circuit leads to the same outcome of memory failure.

Molecular Pathways

A single molecular pathway involving the protein RBAP48 accounts for normal cognitive aging in the dentate gyrus. Small and his collaborators found that the molecule RBAP48 is down-regulated when memory problems occur. Carol Barnes at the University of Arizona confirmed that rats with lower expression of this molecule had the worst memories.

A female doctor with a doctorate in engineering from Tokyo abandoned making plasma television screens and traveled to New York at her own expense to join Scott Small's lab after reading about his imaging work. Researchers now expect about a year to know results from a knockout mouse with the RBAP48 molecule removed.

5. Genetics and the Pathology of Alzheimer's

Alzheimer's disease divides into two distinct categories with very different genetic mechanisms. Early-onset cases strike between thirty and fifty, account for less than 5 percent of cases, and follow Mendelian inheritance. Late-onset Alzheimer's affects people sixty-five and older, driven by multiple risk-factor genes that increase susceptibility.

Late-onset Alzheimer's is driven by complex risk-factor genes and soluble beta-amyloid peptides that attack synapses long before plaques form.

Genetics and Pedigrees

Studying isolated populations gives you the statistical power needed to locate elusive risk genes. Dominicans in a specific region tended to marry within their group and had high rates of intermarriage. This kept the genetic pool enriched and pushed disease rates roughly three times higher than in other local communities.

Researchers like Dr. Angel Piriz and field coordinator Vinny Santana traveled to Navarette and Ginger Alley in the Dominican Republic. They conducted neuropsychological tests and collected blood samples from extended family members like an eighty-three-year-old farmer named Vargas. Richard Mayeux oversaw 185 staff members and inaugurated the WHICAP study in 1988.

Industrial freezers at the New York Brain Bank stored 28,544 blood plasma samples for these genetic evaluations. Early gene discoveries like APP and presenilin explained very rare cases involving less than two hundred people. The common APOE4 gene increases risk without directly causing the disease.

Synaptic Attacks

A debate existed between proponents of beta-amyloid plaques and tau tangles. Evidence showed that the soluble peptide abeta 42 accumulates in synapses and disrupts communication. Plaques may act as a secondary attempt by the brain to sequester harmful peptides rather than cause the primary damage.

A 2004 study published in Nature Neuroscience by Karen Duff and colleagues used live mice imaging. They showed that glowing dendrites and axons wither and break apart when they encounter tomato-red amyloid clumps. Karen Duff received a 7.5 million dollars grant to work on tangle diseases.

Scott Small used high-resolution functional MRI and microarrays to examine specific hippocampal cells. He discovered that retromer dysfunction prevents proper trafficking of amyloid precursor protein cargo. Richard Mayeux, Peter St. George-Hyslop, and Lindsay Farrar collaborated to confirm the gene sorLA. The New York Times published a headline announcing this gene linked to Alzheimer's on January 15, 2007, alongside Nature Genetics.

6. Drug Development Realities

Scientists developing memory drugs routinely give the exact same predictable timeline for availability. Researchers call this answer the five-year plan. Regardless of when you ask or how much time passes, the availability of a memory drug remains perpetually five years away.

Developing brain-targeted drugs involves extremely poor success odds due to rigorous testing gauntlets and the protective blood-brain barrier.

Out of 5,000 compounds tested, only 5 typically make it through preclinical testing to human testing. Only 1 generally receives Food and Drug Administration approval. The preclinical testing gauntlet costs 500 million dollars.

Sention attempted to bypass the side effects of amphetamines by developing a left-hand isomer called C105 for memory enhancement. By utilizing a mirror-image isomer of d-amphetamine, researchers hoped to retain cognitive-boosting benefits while eliminating addictive properties. Sention raised 13 million dollars in inaugural venture financing.

Sention hired Virginia Commonwealth University to run a clinical trial. Recreational amphetamine users were offered a choice between the drug or money to measure addiction potential.

Pharmaceutical Challenges

Gary Lynch developed a class of drugs called ampakines designed to increase the excitatory activity of glutamate. Ampakines target the roughly 90 percent of synapses mediated by excitatory glutamate left largely untreated by traditional pharmacology. Cortex Pharmaceuticals tested ampakines on soldiers and sleep-deprived monkeys who maintained performance on a battery of tests.

Study participants took 1,000 milligrams of CX717 during tests of simulated night-shift work.

Elan Pharmaceuticals attempted to treat Alzheimer's by developing a vaccine designed to clear amyloid plaques using antibodies. Dale Schenk reasoned that injecting beta-amyloid would stimulate antibodies to tag and remove plaques in the brain similarly to a viral vaccine. Elan ran a phase 2 trial of AN-1792 with approximately 300 participants.

The trial had to be permanently halted in March 2002 after 15 participants developed life-threatening brain inflammation.

Upstream Targets

Effective drug development requires targeting primary molecular defects upstream rather than managing symptoms downstream.

Traditional drugs work downstream by managing or clearing toxins after they form. Preventive solutions must target upstream mechanisms like trafficking defects instead of waiting for plaques to appear. Scott Small used a sanitation worker strike analogy to explain how faulty distribution and backed-up cargo cause amyloid production.

7. Dietary Interventions and Brain Plasticity

Adult Neurogenesis

Adult neurogenesis and cognitive health can be supported through dietary interventions, antioxidants, and lifestyle modifications.

Conventional belief held that humans are born with a fixed number of brain cells that only diminish with age. Fred Gage upended this dogma by proving that the adult human hippocampus retains the ability to generate new neurons throughout life.

Fred Gage published seminal research in Nature Medicine in 1998 demonstrating adult human neurogenesis. He demonstrated through research that new neurons are generated from dividing progenitor cells in the dentate gyrus of adult humans.

Dietary Compounds

Normal metabolic processes produce free radicals with unpaired electrons that randomly couple with lipids, proteins, and DNA, causing oxidation. The brain is especially vulnerable due to using 20 percent of the body's metabolic oxygen, and oxidative stress links to premature aging, heart disease, and dementia.

Jim Joseph fed rats freeze-dried blueberry powder and tested them in the Rat Olympics, where they outperformed control rats on balance beams and logrolling.

Anthocyanins in blueberries reduce oxidative stress and promote neurogenesis. Studies showed that a diet enriched with blueberry extract reversed motor deficits and prevented memory loss in transgenic Alzheimer's mice. Human consumption of blueberries shows psychomotor test increases:

• three percent for humans consuming one cup of blueberries;
• six percent for humans consuming two cups of blueberries.

Mars investigated flavanols, which are polyphenols that help improve blood flow, relax blood vessels, and increase antioxidant capacity. Norman Hollenberg found that Kuna Indians drinking native flavanol-rich cocoa lacked hypertension, unlike mainland Kuna who drank processed cocoa.

Herbal memory supplements lack strict regulatory oversight, often failing label consistency and relying on structural claims. Under the Dietary Supplement Health and Education Act of 1994, manufacturers can make structure or function claims without proving clinical effectiveness to the FDA.

8. Cognitive Reserve and Exercise

Aerobic exercise stimulates neurogenesis and building cognitive reserve creates alternative neural pathways that protect against clinical dementia.

Exercise and Brain Growth

Aerobic exercise alone stimulates neurogenesis, increases cerebral blood volume, and improves memory performance in both mice and humans. Experiments by Rusty Gage, Scott Small, and Richard Sloan demonstrated a direct causal link between aerobic exercise and the growth of new neurons in the dentate gyrus. Exercise increases cerebral blood volume and elevates brain-derived neurotrophic factor, which enhances neural plasticity and cell survival.

Scott Small tracked a marathon mouse that ran 300 kilometers in a month, while Richard Sloan coordinated hospital employees entering their workout data into computers to track brain changes.

Studies confirm long-term benefits across human populations. The Karolinska Institute followed more than fifteen hundred people for 35 years. An elderly Hawaiian study linked a daily walking distance of 2 miles to half the risk of developing dementia. A study of nearly twenty thousand nurses linked 1.5 hours of weekly walking time to significantly higher memory scores.

Computer-based cognitive training programs leverage neural plasticity to retrain sensory systems and improve mental clarity in older adults. Michael Merzenich's research proved that the brain's neural map is continuously modifiable through focused learning and skill acquisition. Programs like the Posit Science Brain Fitness program aim to reduce neural noise and sharpen sensory processing, enabling older adults to improve memory and spatial confidence.

At The Heritage life care facility in San Francisco, residents such as Zoe Brown and Elmer George participated in a computer-based brain-fitness class involving rapid auditory tone discrimination exercises over 8 weeks. A multisite, double-blind clinical trial evaluating the Posit Science program at the Mayo Clinic and USC involved 500 participants.

You can engage your auditory system directly through targeted computer exercises:

• Listen for a sequence of high or low tones broadcast through high-fidelity headphones.
• Click the left mouse button when you hear a high tone.
• Click the right mouse button when you hear a low tone.

Cognitive Reserve

Cognitive reserve explains why some individuals tolerate significant brain pathology without showing clinical symptoms of dementia by utilizing alternative neural pathways. Yaakov Stern's research at Columbia University demonstrates that education, demanding jobs, and mental stimulation build an extensive network of alternative neural routes. Similar to a metropolitan road network that bypasses a blocked bridge, a brain with high cognitive reserve can route around damage caused by plaques and tangles.

An Albert Einstein College of Medicine study following nearly five hundred people for twenty-one years found that ballroom dancing reduced the risk of dementia by 76 percent, outperforming passive activities like crossword puzzles.

10 Key Ideas

1. Society suffers from a widespread phobia regarding memory loss, routinely confusing normal everyday age-related forgetfulness with pathological neurodegeneration.
2. Advanced neuroimaging and early screening tools, such as olfactory tests and word-recall assessments, allow clinicians to identify mild cognitive impairment before clinical symptoms emerge.
3. Memory relies on complex neural architecture, synaptic plasticity, and distinct cognitive categories that are vulnerable to biological flaws and stress-induced prefrontal cortex disruption.
4. The aging brain compensates for physiological shrinkage through bilateralism and molecular pathways that preserve cognitive function independently of destructive diseases like Alzheimer's.
5. Late-onset Alzheimer's disease is driven by complex risk-factor genes and soluble beta-amyloid peptides that attack synapses long before plaques form.
6. Developing brain-targeted drugs involves extremely poor success odds due to rigorous testing gauntlets, the protective blood-brain barrier, and the need to target upstream molecular defects.
7. Fred Gage disproved the dogma of a fixed brain cell count by proving that adult human neurogenesis occurs continuously in the hippocampal dentate gyrus.
8. Dietary interventions, including antioxidant-rich blueberries and flavanols, protect the brain from oxidative stress and support neurogenesis.
9. Aerobic exercise stimulates neurogenesis, increases cerebral blood volume, and elevates brain-derived neurotrophic factor to improve memory performance.
10. Building cognitive reserve through complex mental stimulation, physical activity, and education creates alternative neural pathways that protect against clinical dementia.